| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 3.367 | 930 | 2.554 | 3.607 | 2.033 | 201 | 466 | 960 | 503 |
| Total Income - EUR | 0 | 3.367 | 930 | 2.614 | 3.607 | 2.033 | 201 | 466 | 960 | 503 |
| Total Expenses - EUR | 493 | 248 | 367 | 410 | 417 | 186 | 115 | 114 | 546 | 751 |
| Gross Profit/Loss - EUR | -493 | 3.119 | 562 | 2.204 | 3.190 | 1.847 | 86 | 353 | 414 | -248 |
| Net Profit/Loss - EUR | -493 | 3.018 | 535 | 2.125 | 3.082 | 1.790 | 80 | 339 | 357 | -248 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Crisendo Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 978 | 968 | 655 | 352 | 59 | 0 | 0 | 0 | 1.286 | 1.133 |
| Current Assets | 322 | 1.185 | 2.012 | 4.345 | 3.411 | 3.526 | 3.511 | 657 | 1.554 | 1.451 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 203 | 201 | 431 | 672 | 260 | 669 | 250 | 250 | 252 | 102 |
| Cash | 119 | 985 | 1.581 | 3.673 | 3.151 | 2.857 | 3.261 | 406 | 1.301 | 1.350 |
| Shareholders Funds | -944 | 2.083 | 2.582 | 4.660 | 3.438 | 3.509 | 3.511 | 657 | 1.011 | 757 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.245 | 70 | 84 | 36 | 32 | 17 | 0 | 0 | 1.829 | 1.827 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Crisendo Medical Srl